by Cort Johnson | Dec 12, 2018 | Allodynia, Autoimmune, Brain, Gut, Herpes Simplex Virus, Homepage, Ivabradine, IVIG, Migraine, Prefrontal Cortex
It’s always hard to lose a loved one, but the deaths in ME/CFS seem particularly hard. They tend to be quite painful, they often take place in the midst of a non-supportive medical system, and they’re a complete mystery. With no seeming way out it’s... 
by Cort Johnson | Nov 3, 2018 | Autoimmune, Drugs, Energy Production, Genetics, Homepage, Inflammation, Mast cell activation syndrome
The Solve ME/CFS Initiative’s Ramsay Awards are small grants (@$50K – only in the medical field is 50K small) but potentially mighty grants. They are designed to give researchers the funding to produce pilot data needed to get really big grants – the... 
by Cort Johnson | Oct 24, 2018 | Herbs and Botanicals, Homepage, Low Dose Naltrexone, Opioid drugs
This is the last of three blogs emanating from interviews with Jarred Younger at his Neuroinflammation, Fatigue and Pain lab at the University of Alabama at Birmingham and at the 2018 Stanford Symposium Younger wanted to know one thing from his post-doc group studying... 
by Cort Johnson | Oct 13, 2018 | Cannabis, Cymbalta, Dextromethorphan, Fibromyalgia, Homepage, Low Dose Naltrexone, Lyrica, Neuroinflammation, Supplements
“Finding an objective neurochemical change in the brains of people who are used to being told that their problems are imaginary is pretty important…” Marco Loggia Jarred Younger has believed for quite some time that the glial cells in fibromyalgia... 
by Cort Johnson | Oct 10, 2018 | CDC, Definition, Diagnosis, Exercise, HPA axis, Inflammation, Klimas, Mifepristone
Roundtable The Centers for Disease Control (CDC) flew in about 40 people from over two dozen organizations for the one-day CDC Roundtable on Medical Education and ME/CFS. It was a busy 24 hours. Everyone flew in the night before to a hotel near the airport, spent the... 
by Cort Johnson | Sep 19, 2018 | Gut, Homepage, IVIG, Low Dose Naltrexone, Mast cell activation syndrome, POTS, Xifaxin
“The dramatic response to therapy in this patient is remarkable and could help others who suffer from POTS and MCAS.” The authors This, the fourth and last of a series of blogs featuring IVIG, and in this case other treatments, was sparked by attending the 2018...
